\-\ Texto\\:\\ \ \(0\)\
\-\ patient\\ was\\ obese\\ with\\ abdominal\\ bruit\\ appreciated\\ on\\ physical\\ exam\\.\\ \\ laboratory\\ values\\ were\\ remarkable\\ for\\ a\\ triglyceride\\ level\\ of\\ 246\\,\\ hdl\\ of\\ 25\\ and\\ vldl\\ of\\ 49\\.\\ \\ the\\ remainder\\ of\\ the\\ laboratory\\ work\\ up\\ was\\ negative\\.\ \(0\)\
\-\ patient\\ initially\\ underwent\\ 6\\ month\\ follow\\ up\\ cts\\ to\\ assess\\ for\\ stablitiy\\ of\\ the\\ aneurysm\\.\\ \\ type\\ ii\\ endoleaks\\ can\\ be\\ followed\\ as\\ long\\ as\\ the\\ aneurysm\\ sac\\ does\\ not\\ increase\\ in\\ size\\.\\ \\ the\\ sac\\ did\\ demonstrate\\ interval\\ increase\\ in\\ size\\ to\\ a\\ maximum\\ diamter\\ of\\ 5\\.4\\ cm\\ at\\ one\\-year\\ follow\\ up\\.\\ \\ the\\ initial\\ treatment\\ undertaken\\ was\\ laparoscopic\\ ligation\\ of\\ the\\ inferior\\ mesenteric\\ artery\\.\\ this\\ was\\ unsuccessful\\ and\\ the\\ next\\ intervention\\ was\\ angiography\\ and\\ embolization\\ of\\ the\\ lumbar\\ arteries\\.\\ \\ this\\ proved\\ to\\ be\\ successful\\.\ \(0\)\
\-\ ct\\ imaging\\ through\\ the\\ abdomen\\ prior\\ to\\ stent\\ placement\\ demonstrates\\ fusiform\\ aneurysmal\\ dilatation\\ of\\ the\\ abdominal\\ aorta\\ in\\ the\\ infrarenal\\ portion\\.\\ \\ the\\ dilatation\\ ends\\ approximately\\ 1\\ cm\\ above\\ the\\ aortic\\ bifurcation\\.\\ \\ the\\ maximum\\ diameter\\ of\\ the\\ aneurysm\\ is\\ 4\\.1\\ cm\\.\\ \\ thrombotic\\ plaque\\ is\\ present\\ with\\ the\\ aneurysm\\.\\ \ \(0\)\
\-\ post\\ stent\\ placement\\ imaging\\ demonstrates\\ an\\ intact\\ stent\\ graft\\ which\\ extends\\ from\\ the\\ infrarenal\\ level\\ into\\ both\\ iliacs\\ without\\ evidence\\ of\\ leak\\ at\\ the\\ distal\\ or\\ proximal\\ ends\\.\\ \\ the\\ renal\\ arteries\\ appear\\ widely\\ patent\\ and\\ well\\ opacified\\.\\ \\ there\\ is\\ curvilinear\\ dense\\ contrast\\ material\\ which\\ extends\\ anteriorly\\ from\\ the\\ left\\ aspect\\ of\\ the\\ stent\\ graft\\ in\\ the\\ superior\\ most\\ aspect\\ of\\ the\\ aneurysm\\.\\ \\ this\\ is\\ most\\ consistent\\ with\\ a\\ type\\ ii\\ endoleak\\.\ \(0\)\
\-\ type\\ ii\\ endograft\\ leak\ \(0\)\
\-\ endograft\\ leak\ \(2\)\
\-\ 67\\-year\\ old\\ male\\ with\\ history\\ of\\ abdominal\\ aortic\\ aneurysm\\,\\ which\\ was\\ first\\ diagnosed\\ in\\ 1998\\.\\ \\ the\\ patient\\ was\\ lost\\ to\\ follow\\ up\\ until\\ 2003\\.\\ \\ repeat\\ imaging\\ at\\ that\\ time\\ demonstrated\\ an\\ increase\\ in\\ the\\ size\\ of\\ the\\ aneurysm\\ to\\ a\\ maximum\\ diamter\\ of\\ 5\\.4\\ cm\\.\ \(0\)\
\-\ risk\\ of\\ abdominal\\ aortic\\ aneurysm\\ rupture\\ is\\ related\\ to\\ the\\ size\\ of\\ the\\ aneurysm\\,\\ with\\ a\\ reported\\ annual\\ risk\\ of\\ rupture\\ between\\ 5\\-10\\%\\ for\\ aneurysms\\ measuring\\ between\\ 5\\ and\\ 6\\ cm\\.\\ \\ repair\\ of\\ aneurysms\\ can\\ be\\ accomplished\\ with\\ open\\ surgical\\ repair\\ or\\ via\\ endovascular\\ stent\\ graft\\ placement\\.\\ \\ the\\ most\\ common\\ complication\\ that\\ occurs\\ after\\ endovascular\\ stent\\ graft\\ placement\\ is\\ persistent\\ arterial\\ flow\\ within\\ the\\ aneurysm\\ sac\\,\\ also\\ known\\ as\\ an\\ endoleak\\.\\ \\ the\\ reported\\ incidence\\ of\\ endoleak\\ is\\ 3\\-44\\%\\.\\ \\ there\\ are\\ five\\ distinct\\ types\\ of\\ endoleaks\\ with\\ type\\ ii\\ being\\ the\\ most\\ common\\.\\ \\ this\\ type\\ of\\ leak\\ occurs\\ secondary\\ to\\ retrograde\\ flow\\ into\\ the\\ aneurysm\\ sac\\ from\\ patent\\ side\\ branches\\,\\ usually\\ lumbar\\ arteries\\ or\\ the\\ inferior\\ mesenteric\\ artery\\.\\ \\ \\ \ \(0\)\
\-\ ct\\ angiography\\ is\\ the\\ primary\\ method\\ for\\ imaging\\ and\\ evaluating\\ patients\\ after\\ stent\\ graft\\ placement\\.\\ \\ when\\ a\\ type\\ ii\\ endoleak\\ is\\ identified\\ on\\ ct\\,\\ it\\ can\\ be\\ managed\\ with\\ embolization\\ or\\ observation\\,\\ in\\ the\\ hope\\ that\\ the\\ endoleak\\ will\\ seal\\ spontaneously\\.\\ \\ in\\ this\\ case\\,\\ an\\ endoleak\\ was\\ observed\\.\\ \\ however\\,\\ the\\ patient\\ was\\ followed\\ with\\ serial\\ ct\\ scans\\ until\\ increase\\ of\\ the\\ aneurysm\\ sac\\ was\\ identified\\.\\ \\ at\\ this\\ point\\ the\\ patient\\ underwent\\ ligation\\ of\\ the\\ inferior\\ mesenteric\\ artery\\,\\ which\\ was\\ not\\ successful\\ in\\ stopping\\ the\\ leak\\.\\ \\ angiography\\ and\\ embolization\\ was\\ then\\ performed\\ of\\ the\\ lumbar\\ arteries\\,\\ which\\ was\\ successful\\ in\\ stopping\\ the\\ leak\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ aneurysm\\:\\ 0\\.31618254333296125\ \(0\)\
\-\ the\\:\\ 0\\.31071964063458773\ \(0\)\
\-\ endoleak\\:\\ 0\\.29205480536865547\ \(0\)\
\-\ stent\\:\\ 0\\.24439226582853135\ \(0\)\
\-\ leak\\:\\ 0\\.2221045206472136\ \(0\)\
\-\ graft\\:\\ 0\\.18030594170789363\ \(0\)\
\-\ of\\:\\ 0\\.17607138094458352\ \(0\)\
\-\ was\\:\\ 0\\.15678080566513952\ \(0\)\
\-\ sac\\:\\ 0\\.15406907158028432\ \(0\)\
\-\ type\\:\\ 0\\.13928472172060002\ \(0\)\
\-\ ii\\:\\ 0\\.13641838343861165\ \(0\)\
\-\ placement\\:\\ 0\\.13510889670805487\ \(0\)\
\-\ increase\\:\\ 0\\.11111665564380346\ \(0\)\
\-\ diamter\\:\\ 0\\.11068072702818109\ \(0\)\
\-\ maximum\\:\\ 0\\.1101854756038323\ \(0\)\
\-\ arteries\\:\\ 0\\.10985910040399272\ \(0\)\
\-\ endoleaks\\:\\ 0\\.10576134349168329\ \(0\)\
\-\ successful\\:\\ 0\\.10080448971998947\ \(0\)\
\-\ cm\\:\\ 0\\.09936920570062346\ \(0\)\
\-\ angiography\\:\\ 0\\.09595210428604976\ \(0\)\
\-\ size\\:\\ 0\\.09372319418349921\ \(0\)\
\-\ endograft\\:\\ 0\\.09243221825305402\ \(0\)\
\-\ stopping\\:\\ 0\\.0911539114992562\ \(0\)\
\-\ embolization\\:\\ 0\\.09047615351537572\ \(0\)\
\-\ mesenteric\\:\\ 0\\.0896360487182439\ \(0\)\
\-\ in\\:\\ 0\\.08608513033810222\ \(0\)\
\-\ is\\:\\ 0\\.08529045840746308\ \(0\)\
\-\ infrarenal\\:\\ 0\\.08471596201833685\ \(0\)\
\-\ ends\\:\\ 0\\.08471596201833685\ \(0\)\
\-\ lumbar\\:\\ 0\\.08382806156938889\ \(0\)\
\-\ aortic\\:\\ 0\\.08023037329169948\ \(0\)\
\-\ ligation\\:\\ 0\\.08003683767246275\ \(0\)\
\-\ which\\:\\ 0\\.07867538575458712\ \(0\)\
\-\ endovascular\\:\\ 0\\.07666841714275707\ \(0\)\
\-\ abdominal\\:\\ 0\\.07570479686265118\ \(0\)\
\-\ aneurysms\\:\\ 0\\.07403484021573788\ \(0\)\
\-\ imaging\\:\\ 0\\.07274365175023155\ \(0\)\
\-\ most\\:\\ 0\\.07203722406752334\ \(0\)\
\-\ this\\:\\ 0\\.07134467869221335\ \(0\)\
\-\ inferior\\:\\ 0\\.07062633232737218\ \(0\)\
\-\ to\\:\\ 0\\.06920874959264052\ \(0\)\
\-\ up\\:\\ 0\\.06847045907093448\ \(0\)\
\-\ artery\\:\\ 0\\.06447536997903644\ \(0\)\
\-\ patent\\:\\ 0\\.06274150141004346\ \(0\)\
\-\ with\\:\\ 0\\.06098420199902622\ \(0\)\
\-\ until\\:\\ 0\\.05759101197845137\ \(0\)\
\-\ extends\\:\\ 0\\.05699542282568647\ \(0\)\
\-\ dilatation\\:\\ 0\\.056497236426665404\ \(0\)\
\-\ patient\\:\\ 0\\.05627577188173265\ \(0\)\
\-\ be\\:\\ 0\\.05615088697799885\ \(0\)\
\-\ follow\\:\\ 0\\.05596472857016197\ \(0\)\
\-\ rupture\\:\\ 0\\.05595185505359453\ \(0\)\
\-\ stablitiy\\:\\ 0\\.055340363514090544\ \(0\)\
\-\ occurs\\:\\ 0\\.05456735337544466\ \(0\)\
\-\ can\\:\\ 0\\.05447826690047638\ \(0\)\
\-\ repair\\:\\ 0\\.053541444575312985\ \(0\)\
\-\ an\\:\\ 0\\.052930802945951046\ \(0\)\
\-\ ct\\:\\ 0\\.05269725556754645\ \(0\)\
\-\ at\\:\\ 0\\.05228245255563814\ \(0\)\
\-\ triglyceride\\:\\ 0\\.05113549266302481\ \(0\)\
\-\ hdl\\:\\ 0\\.05113549266302481\ \(0\)\
\-\ vldl\\:\\ 0\\.05113549266302481\ \(0\)\
\-\ iliacs\\:\\ 0\\.05113549266302481\ \(0\)\
\-\ laboratory\\:\\ 0\\.05025778123230925\ \(0\)\
\-\ and\\:\\ 0\\.05005438603041658\ \(0\)\
\-\ reported\\:\\ 0\\.049847853975176354\ \(0\)\
\-\ seal\\:\\ 0\\.04978182660069383\ \(0\)\
\-\ risk\\:\\ 0\\.04945132545895401\ \(0\)\
\-\ identified\\:\\ 0\\.049067347442603076\ \(0\)\
\-\ or\\:\\ 0\\.048153361602551056\ \(0\)\
\-\ 246\\:\\ 0\\.04774066948480036\ \(0\)\
\-\ underwent\\:\\ 0\\.04767617761773475\ \(0\)\
\-\ followed\\:\\ 0\\.04673619346732533\ \(0\)\
\-\ hope\\:\\ 0\\.04621610912652701\ \(0\)\
\-\ flow\\:\\ 0\\.046098282984681514\ \(0\)\
\-\ that\\:\\ 0\\.04505135680866444\ \(0\)\
\-\ between\\:\\ 0\\.044968845493072764\ \(0\)\
\-\ aspect\\:\\ 0\\.044649545679913784\ \(0\)\
\-\ cts\\:\\ 0\\.043117263981379196\ \(0\)\
\-\ undertaken\\:\\ 0\\.043117263981379196\ \(0\)\
\-\ thrombotic\\:\\ 0\\.04201123827546128\ \(0\)\
\-\ for\\:\\ 0\\.04195361133108581\ \(0\)\
\-\ level\\:\\ 0\\.04180641790222745\ \(0\)\
\-\ as\\:\\ 0\\.04170574412469101\ \(0\)\
\-\ opacified\\:\\ 0\\.041372084898562374\ \(0\)\
\-\ from\\:\\ 0\\.04123049574433617\ \(0\)\
\-\ bruit\\:\\ 0\\.041076106865485726\ \(0\)\
\-\ unsuccessful\\:\\ 0\\.040793900339627445\ \(0\)\
\-\ widely\\:\\ 0\\.040018418836231376\ \(0\)\
\-\ proved\\:\\ 0\\.03978049240715319\ \(0\)\
\-\ common\\:\\ 0\\.03924959664482403\ \(0\)\
\-\ method\\:\\ 0\\.038153110158102695\ \(0\)\
\-\ laparoscopic\\:\\ 0\\.037977261720337906\ \(0\)\
\-\ fusiform\\:\\ 0\\.037320800638904285\ \(0\)\
\-\ bifurcation\\:\\ 0\\.037320800638904285\ \(0\)\
\-\ accomplished\\:\\ 0\\.03701742010786894\ \(0\)\
\-\ retrograde\\:\\ 0\\.03701742010786894\ \(0\)\
\-\ into\\:\\ 0\\.036790468934374765\ \(0\)\
\-\ distinct\\:\\ 0\\.0367284918679441\ \(0\)\
\-\ plaque\\:\\ 0\\.03631936970207655\ \(0\)\
\-\ lost\\:\\ 0\\.03618890561308232\ \(0\)\
\-\ obese\\:\\ 0\\.03581354798516565\ \(0\)\
\-\ curvilinear\\:\\ 0\\.03581354798516565\ \(0\)\
\-\ spontaneously\\:\\ 0\\.03523536342623072\ \(0\)\
\-\ evaluating\\:\\ 0\\.03480948007967026\ \(0\)\
\-\ demonstrates\\:\\ 0\\.03476999640835542\ \(0\)\
\-\ branches\\:\\ 0\\.0343160092587619\ \(0\)\
\-\ remarkable\\:\\ 0\\.03412933772031281\ \(0\)\
\-\ aneurysmal\\:\\ 0\\.03394823930703696\ \(0\)\
\-\ managed\\:\\ 0\\.03385967793382764\ \(0\)\
\-\ after\\:\\ 0\\.03357456276315452\ \(0\)\
\-\ observation\\:\\ 0\\.03245348906439843\ \(0\)\
\-\ next\\:\\ 0\\.03231561162201381\ \(0\)\
\-\ types\\:\\ 0\\.032180798377862994\ \(0\)\
\-\ assess\\:\\ 0\\.03198403476201659\ \(0\)\
\-\ annual\\:\\ 0\\.03198403476201659\ \(0\)\
\-\ values\\:\\ 0\\.031919840021974774\ \(0\)\
\-\ serial\\:\\ 0\\.031856317490513\ \(0\)\
\-\ complication\\:\\ 0\\.031429363202767936\ \(0\)\
\-\ anteriorly\\:\\ 0\\.03137075070502173\ \(0\)\
\-\ interval\\:\\ 0\\.03131269910102327\ \(0\)\
\-\ five\\:\\ 0\\.03125519775747459\ \(0\)\
\-\ appreciated\\:\\ 0\\.03119823634061617\ \(0\)\
\-\ observed\\:\\ 0\\.030813814316056863\ \(0\)\
\-\ dense\\:\\ 0\\.030502651428182006\ \(0\)\
\-\ remainder\\:\\ 0\\.03045230801623007\ \(0\)\
\-\ repeat\\:\\ 0\\.0303528574885543\ \(0\)\
\-\ scans\\:\\ 0\\.03011113840769618\ \(0\)\
\-\ incidence\\:\\ 0\\.02978813874274993\ \(0\)\
\-\ material\\:\\ 0\\.029148985365851015\ \(0\)\
\-\ intervention\\:\\ 0\\.029068635233240034\ \(0\)\
\-\ open\\:\\ 0\\.02860767840573748\ \(0\)\
\-\ point\\:\\ 0\\.02860767840573748\ \(0\)\
\-\ arterial\\:\\ 0\\.028497711412843234\ \(0\)\
\-\ via\\:\\ 0\\.028283582842256152\ \(0\)\
\-\ work\\:\\ 0\\.02821385395587546\ \(0\)\
\-\ aorta\\:\\ 0\\.02811074077094808\ \(0\)\
\-\ diameter\\:\\ 0\\.02781151783470532\ \(0\)\
\-\ there\\:\\ 0\\.027538163048521472\ \(0\)\
\-\ not\\:\\ 0\\.02732218271158996\ \(0\)\
\-\ appear\\:\\ 0\\.027254012343406485\ \(0\)\
\-\ initially\\:\\ 0\\.027136784611974118\ \(0\)\
\-\ measuring\\:\\ 0\\.026770722287656493\ \(0\)\
\-\ persistent\\:\\ 0\\.02666239179597922\ \(0\)\
\-\ related\\:\\ 0\\.02629778057711628\ \(0\)\
\-\ diagnosed\\:\\ 0\\.02506667113406407\ \(0\)\
\-\ intact\\:\\ 0\\.02504607231520781\ \(0\)\
\-\ above\\:\\ 0\\.024964369446204913\ \(0\)\
\-\ did\\:\\ 0\\.02482398491947342\ \(0\)\
\-\ portion\\:\\ 0\\.024745200093624947\ \(0\)\
\-\ 25\\:\\ 0\\.024514804821720627\ \(0\)\
\-\ then\\:\\ 0\\.02449599443044937\ \(0\)\
\-\ being\\:\\ 0\\.024113879314746914\ \(0\)\
\-\ does\\:\\ 0\\.02392293419646316\ \(0\)\
\-\ side\\:\\ 0\\.02390586991988235\ \(0\)\
\-\ first\\:\\ 0\\.023352522023376107\ \(0\)\
\-\ initial\\:\\ 0\\.02321412028676667\ \(0\)\
\-\ long\\:\\ 0\\.022946443938691975\ \(0\)\
\-\ superior\\:\\ 0\\.022497918517006704\ \(0\)\
\-\ known\\:\\ 0\\.022404072613925404\ \(0\)\
\-\ will\\:\\ 0\\.022272476427078792\ \(0\)\
\-\ approximately\\:\\ 0\\.022080284651099492\ \(0\)\
\-\ usually\\:\\ 0\\.02178490721663968\ \(0\)\
\-\ proximal\\:\\ 0\\.02161902022294152\ \(0\)\
\-\ renal\\:\\ 0\\.021549291336560826\ \(0\)\
\-\ negative\\:\\ 0\\.0214235001950383\ \(0\)\
\-\ primary\\:\\ 0\\.021278124570481664\ \(0\)\
\-\ demonstrated\\:\\ 0\\.021267084810702545\ \(0\)\
\-\ abdomen\\:\\ 0\\.02111460129163623\ \(0\)\
\-\ month\\:\\ 0\\.021050406551594413\ \(0\)\
\-\ when\\:\\ 0\\.020903208951113725\ \(0\)\
\-\ on\\:\\ 0\\.020902394560484712\ \(0\)\
\-\ through\\:\\ 0\\.020599321730053074\ \(0\)\
\-\ time\\:\\ 0\\.02051104674165789\ \(0\)\
\-\ secondary\\:\\ 0\\.02051104674165789\ \(0\)\
\-\ however\\:\\ 0\\.020481904909838058\ \(0\)\
\-\ performed\\:\\ 0\\.020472221992659488\ \(0\)\
\-\ distal\\:\\ 0\\.020106159668341856\ \(0\)\
\-\ evidence\\:\\ 0\\.01964164929525952\ \(0\)\
\-\ patients\\:\\ 0\\.019467006291442945\ \(0\)\
\-\ prior\\:\\ 0\\.019361360617833136\ \(0\)\
\-\ both\\:\\ 0\\.019297250680876888\ \(0\)\
\-\ post\\:\\ 0\\.018829492689205838\ \(0\)\
\-\ physical\\:\\ 0\\.018763433818758505\ \(0\)\
\-\ consistent\\:\\ 0\\.018763433818758505\ \(0\)\
\-\ without\\:\\ 0\\.01825265009384776\ \(0\)\
\-\ demonstrate\\:\\ 0\\.017989996675407342\ \(0\)\
\-\ were\\:\\ 0\\.017837695463032884\ \(0\)\
\-\ present\\:\\ 0\\.01775676814463253\ \(0\)\
\-\ it\\:\\ 0\\.017713634977368407\ \(0\)\
\-\ exam\\:\\ 0\\.017419996453123074\ \(0\)\
\-\ case\\:\\ 0\\.01738499820417771\ \(0\)\
\-\ surgical\\:\\ 0\\.016818987096560947\ \(0\)\
\-\ contrast\\:\\ 0\\.01681369128974325\ \(0\)\
\-\ well\\:\\ 0\\.016755740515076452\ \(0\)\
\-\ treatment\\:\\ 0\\.016484029400701893\ \(0\)\
\-\ also\\:\\ 0\\.01627703405877233\ \(0\)\
\-\ within\\:\\ 0\\.01593783318275818\ \(0\)\
\-\ male\\:\\ 0\\.015407319888718116\ \(0\)\
\-\ history\\:\\ 0\\.013220978324483745\ \(0\)\
\-\ are\\:\\ 0\\.013130889609654734\ \(0\)\
\-\ left\\:\\ 0\\.011804399714133027\ \(0\)\
\-\ old\\:\\ 0\\.010241583569261253\ \(0\)\
